Skip to main navigation

Top bar

Biogen.com Information Request Sign up for Alerts Search

Investor Relations

Overview

News

Events Presentations

SEC Filings Annual Reports

Stock Quote & Chart Analyst Coverage Investor FAQs

Governance Documents Committee Composition & Charters Leadership Code of Business Conduct Contact the Board

News

News

News Category

Year

April 29, 2008

Genentech and Biogen Idec Announce Top-Line Results from Phase II/III Clinical Study of Rituxan in Systemic Lupus Erythematosus

April 23, 2008

Biogen Idec Reports First Quarter 2008 Results

April 17, 2008

Biogen Idec Announces Slate of Directors for Annual Meeting of Shareholders

April 16, 2008

Data Presented at the 60th Annual Meeting of the American Academy of Neurology Offers Additional Support for Plasma Exchange as a Potential Tool to Accelerate TYSABRI(R) Removal

April 15, 2008

Biogen Idec and Elan Present New TYSABRI(R) Data at the 60th Annual Meeting of the American Academy of Neurology

April 15, 2008

Biogen Idec Announces Multiple Sclerosis Franchise and Pipeline Presentations at the 60th Annual Meeting of the American Academy of Neurology

April 14, 2008

Genentech and Biogen Idec Announce Top-Line Results from a Phase II/III Clinical Trial of Rituxan in Primary-Progressive Multiple Sclerosis

April 1, 2008

Biogen Idec to Report First Quarter 2008 Financial Results on April 23, 2008

March 24, 2008

Researchers Report Neublastin Virtually Restores Complete Long-Term Sensory Motor Function in Preclinical Studies

March 10, 2008

Biogen Idec to Present at the Cowen & Company 28th Annual Healthcare Conference

Pagination

First page
Previous page
…
Page 71
Page 72
Page 73
Page 74
Page 75
Page 76
Current page 77
Page 78
Page 79
Next page
Last page

Displaying 761 - 770 of 783

Footer

Investors
Careers
Our Stories
Contact Us

Follow us

Bottom

Privacy Policy
Terms & Conditions
Forward-Looking Statements
Community Guidelines

Investor Relations

Overview

News

Events & Presentations

Events
Presentations

Financials

SEC Filings
Annual Reports

Stock Information

Stock Quote & Chart
Analyst Coverage
Investor FAQs

Corporate Governance

Governance Documents
Committee Composition & Charters
Leadership
Code of Business Conduct
Contact the Board

Top bar

Biogen.com

Information Request

Sign up for Alerts

Search

Follow us